Trials / Sponsors / Shenzhen MagicRNA Biotechnology Co., Ltd
Shenzhen MagicRNA Biotechnology Co., Ltd
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases Autoimmune Disease, Systemic Lupus Erythematosus, Systemic Sclerosis (SSc) | Phase 1 | 2026-04-28 |
| Terminated | Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG) Refractory Myasthenia Gravis | N/A | 2026-01-19 |
| Recruiting | Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs） Systemic Lupus Erythematosus, Scleroderma, Rheumatoid Arthritis | Phase 1 | 2025-03-16 |